Stevanato Group
Develops pharmaceutical containment, delivery, diagnostic, and manufacturing solutions for drug-development and production workflows.
$21.15
After-hours close+0.07 (+0.33%)
At close$21.08(−5.47%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 16.39%44.76M sharesInsiders 0.29%797.1K sharesOther 83.32%227.46M shares
Shares outstanding 273.01M · Float 273.01M · 100.0% free float
Institutions13F, as of Jun 30, 2026
126 holders · 44.76M shares · 23 new positions · 61 increased · 51 reduced · 32 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Conestoga Capital Advisors, LLC | 7.01M | 2.57% | −1.48M | Jul 24, 2026 |
| Neuberger Berman Group LLC | 5.62M | 2.06% | +1.15M | Aug 13, 2026 |
| Timessquare Capital Management, LLC | 3.47M | 1.27% | −15.1K | Aug 7, 2026 |
| Van Berkom & Associates Inc. | 2.97M | 1.09% | +2.80M | Aug 5, 2026 |
| Artisan Partners Limited Partnership | 2.60M | 0.95% | +311.5K | Aug 13, 2026 |
| Bamco Inc /NY/ | 2.49M | 0.91% | −5.6K | Aug 14, 2026 |
| Morgan Stanley | 1.31M | 0.48% | −11.2K | Aug 13, 2026 |
| Credit Agricole S A | 1.30M | 0.48% | +926.3K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Conestoga Capital Advisorsincl. Conestoga Funds | 16.74% | 8.32M | 13G | Jan 9, 2026 ↗ |
| Neuberger Berman Group LLC | 10.00% | 4.96M | 13G | Dec 3, 2025 ↗ |
| T. Rowe Price Investment Management, Inc. | 6.50% | 3.22M | 13G | May 15, 2026 ↗ |
| Van Berkom & Associates Inc. | 6.00% | 2.97M | 13G | Aug 4, 2026 ↗ |
| Wellington Investment Advisors Holdings LLPincl. Wellington Management Group LLP, Wellington Group Holdings LLP +1 more | 5.43% | 2.69M | 13G | Nov 8, 2024 ↗ |
| Artisan Partners Asset Management Inc. | 5.20% | 2.60M | 13G | Aug 13, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Mauro Stocchi | officer: See Remarks | 407.0K | 0.15% | Jun 26, 2026 |
| Fabrizio Bonanni | director | 119.7K | 0.04% | Mar 18, 2026 |
| Lago Marco Dal | officer: Chief Financial Officer | 81.1K | 0.03% | Aug 10, 2026 |
| Madhavan Balachandran | director | 69.5K | 0.03% | Jun 26, 2026 |
| William J. Federici | director | 58.6K | 0.02% | Jun 26, 2026 |
| Donald E. Jr Morel | director | 37.4K | 0.01% | Jun 26, 2026 |
| Sue-Jean Lin | director | 7.0K | 0.00% | Jun 26, 2026 |
| Karen Flynn | director | 5.8K | 0.00% | Jun 26, 2026 |
| Luciano Santel | director | 4.7K | 0.00% | Aug 10, 2026 |
| Alvise Spinazzi | director | 3.3K | 0.00% | Mar 18, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 7, 2026 | Elisabetta Magistrettidirector | Sale | 2,045 | $20.09 | 2,930 |
| Aug 7, 2026 | Lago Marco Dalofficer: Chief Financial Officer | Sale | 4,209 | $20.09 | 81,144 |
| Aug 7, 2026 | Luciano Santeldirector | Sale | 2,023 | $20.09 | 4,739 |
| Jun 15, 2026 | William J. Federicidirector | Sale | 1,493 | $17.09 | 26,991 |
| Jun 15, 2026 | Karen Flynndirector | Sale | 1,493 | $17.09 | 5,757 |
| Jun 15, 2026 | Donald E. Jr Moreldirector | Sale | 1,493 | $17.09 | 37,424 |
| Jun 15, 2026 | Madhavan Balachandrandirector | Sale | 1,493 | $17.09 | 69,458 |
CongressHouse and Senate disclosures
Not reported.